Bain Capital Tech Opportunities Leads $145M Series C Investment in BioCatch
April 15, 2020
BioCatch, a leader in behavioral biometrics for fraud detection, closed a $145 million Series C round led by Bain Capital Tech Opportunities with participation from Industry Ventures, American Express Ventures, CreditEase, Maverick Ventures, OurCrowd and others. The growth capital will accelerate BioCatch’s expansion, broaden product offerings and support entry into new verticals and geographies.
- Buyers
- Bain Capital Tech Opportunities, Industry Ventures, American Express Ventures, CreditEase, Maverick Ventures, OurCrowd
- Targets
- BioCatch
- Industry
- Cybersecurity
- Location
- Tel Aviv, Israel
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
Visa to Acquire BioCatch for $2.4 Billion to Expand Fraud Prevention Capabilities
August 6, 2026
Cybersecurity
Visa has entered into an agreement to acquire BioCatch for $2.4 billion in cash. The deal will combine BioCatch’s behavioral and device intelligence (AI/ML signals) with Visa’s existing cybersecurity, fraud prevention, risk, and payment security offerings to stop account takeovers and financial scams earlier in the customer journey.
-
Bain Capital Credit Invests $145M Growth Capital in DTiQ
October 14, 2024
Cloud & SaaS
DTiQ received a $145 million growth investment from Bain Capital's Private Credit Group to accelerate its shift to a higher SaaS growth model, expand AI- and computer-vision-powered video analytics offerings, and support geographic expansion. The funding will help DTiQ broaden its SaaS product portfolio for restaurant, convenience store and specialty retail operators and accelerate product innovation and market expansion.
-
Permira Growth Opportunities Acquires Majority Stake in BioCatch at $1.3bn Valuation
May 2, 2024
Cybersecurity
Permira Growth Opportunities II, advised by Permira, agreed to acquire a majority stake in behavioral-biometric fraud-detection firm BioCatch in a secondary transaction valuing the company at $1.3 billion. Existing investors Sapphire Ventures and Macquarie Capital are increasing their investments, while shares were bought primarily from Bain Capital Tech Opportunities and Maverick Ventures to support BioCatch's global expansion, product roadmap and continued growth.
-
Bain Capital Tech Opportunities Invests $150M Growth Capital in Ataccama
June 22, 2022
Data & Analytics
Bain Capital Tech Opportunities has made a $150 million minority growth investment in Ataccama to accelerate go-to-market efforts, product innovation and global expansion. Ataccama, a Toronto-based unified data management platform provider, has been growing rapidly—doubling ARR in 2021 and employing more than 450 people across 10 offices.
-
Bain Capital Tech Opportunities Invests $150M in Axtria
May 13, 2021
Cloud & SaaS
Axtria, a Berkley Heights–based provider of cloud software and data analytics for the life sciences industry, received a $150 million growth investment from Bain Capital Tech Opportunities. The capital will be used to accelerate Axtria's expansion of its life-sciences-focused SaaS platforms, embed AI/ML capabilities across products, and support organic growth and M&A initiatives.
-
BioCatch Acquires AimBrain
February 11, 2020
Cybersecurity
BioCatch has acquired AimBrain, integrating AimBrain’s multimodal biometric authentication technology into BioCatch’s behavioral biometrics platform to strengthen digital identity and fraud-detection capabilities. The AimBrain team will join BioCatch as the companies combine technologies to better serve banks and financial institutions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.